Envoy Medical (ANZU) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Envoy Medical Revenue Highlights


Latest Revenue (Y)

$316.00K

Latest Revenue (Q)

$68.00K

Envoy Medical Revenue by Period


Envoy Medical Revenue by Year

DateRevenueChange
2023-12-31$316.00K33.33%
2022-12-31$237.00K-23.55%
2021-12-31$310.00K100.00%
2020-12-31--

Envoy Medical generated $316.00K in revenue during NA 2023, up 33.33% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Envoy Medical Revenue by Quarter

DateRevenueChange
2024-06-30$68.00K15.25%
2024-03-31$59.00K-37.89%
2023-12-31$95.00K18.75%
2023-09-30$80.00K26.98%
2023-06-30$63.00K-19.23%
2023-03-31$78.00K290.00%
2022-12-31$20.00K-64.91%
2022-09-30$57.00K-3.39%
2022-06-30$59.00K-41.58%
2022-03-31$101.00K100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--

Envoy Medical generated $68.00K in revenue during Q2 2024, up 15.25% compared to the previous quarter, and up 87.18% compared to the same period a year ago.

Envoy Medical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ANZUEnvoy Medical$316.00K$68.00K
ARIZArisz Acquisition--

ANZU Revenue FAQ


Envoy Medical's yearly revenue for 2023 was $316K, representing an increase of 33.33% compared to 2022. The company's yearly revenue for 2022 was $237K, representing a decrease of -23.55% compared to 2021. ANZU's yearly revenue for 2021 was $310K, representing an increase of 100.00% compared to 2020.

Envoy Medical's quarterly revenue for Q2 2024 was $68K, a 15.25% increase from the previous quarter (Q1 2024), and a 7.94% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $59K, a -37.89% decrease from the previous quarter (Q4 2023), and a -24.36% decrease year-over-year (Q1 2023). ANZU's quarterly revenue for Q4 2023 was $95K, a 18.75% increase from the previous quarter (Q3 2023), and a 375.00% increase year-over-year (Q4 2022).

Envoy Medical's revenue growth rate for the last 3 years (2021-2023) was 1.94%